文献速递妇科肿瘤

宫颈小细胞癌患者的预后:SEER数据库与中国多中心登记数据的回顾性研究

The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry.
PubMed 文献 · Lancet Oncol · 2023-01-01

该回顾性研究纳入SEER队列610例和中国多中心队列678例宫颈小细胞癌患者,采用Kaplan-Meier分析、倾向性评分匹配和Cox回归评估手术与预后关系。两个队列均显示手术与更好预后相关,局部晚期患者和IB3-IIA2期患者也可能从手术中获益,尽管指南推荐非手术方法为一线治疗。

要点

  • SEER队列手术与更好预后相关(HR 0.65,95%CI 0.48-0.88,p=0.0058)。
  • 中国队列手术与更好预后相关(HR 0.53,95%CI 0.37-0.76,p=0.0005)。
  • 局部晚期患者两个队列手术均为保护因素(SEER HR 0.61,中国HR 0.59)。

核心结论

  • 本研究提供证据表明手术改善宫颈小细胞癌患者的结局。
  • 尽管指南推荐非手术方法作为一线治疗,局部晚期或IB3-IIA2期癌症患者可能从手术中获益。

研究设计与样本

  • 回顾性研究,收集SEER 18注册队列和中国多机构登记数据。
  • SEER队列纳入2000年1月1日至2018年12月31日诊断为宫颈小细胞癌的女性。
  • 中国队列纳入2006年6月1日至2022年4月30日诊断的女性。
  • 两个队列均限20岁以上确诊宫颈小细胞癌的女性,SEER排除手术状态未知者,中国登记排除失访或宫颈小细胞癌非原发恶性肿瘤者。
  • 共纳入1288例参与者,SEER队列610例,中国队列678例。

主要发现

  • 单变量和多变量Cox回归分析显示手术与更好预后相关(SEER HR 0.65,95%CI 0.48-0.88,p=0.0058;中国HR 0.53,95%CI 0.37-0.76,p=0.0005)。
  • 亚组分析中,手术在局部晚期患者中仍为保护因素(SEER HR 0.61,95%CI 0.39-0.94,p=0.024;中国HR 0.59,95%CI 0.37-0.95,p=0.029)。
  • SEER队列倾向性评分匹配后,局部晚期患者手术保护效应仍存在(HR 0.52,95%CI 0.32-0.84,p=0.0077)。
  • 中国登记中,IB3-IIA2期癌症患者手术与更好结局相关(HR 0.17,95%CI 0.05-0.50,p=0.0015)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Small cell carcinoma of the cervix is a rare but poor prognosis pathological type of cervical cancer, for which advice in clinical guidelines is unspecific. We therefore aimed to investigate the factors and treatment methods that affect the prognosis of patients with small cell carcinoma of the cervix. METHODS: In this retrospective study, we collected data from the Surveillance, Epidemiology, and End Results (SEER) 18 registries cohort and a Chinese multi-institutional registry. The SEER cohort included females diagnosed with small cell carcinoma of the cervix between Jan 1, 2000, and Dec 31, 2018, whereas the Chinese cohort included women diagnosed between Jun 1, 2006, and April 30, 2022. In both cohorts, eligibility was limited to female patients older than 20 years with a confirmed diagnosis of small cell carcinoma of the cervix. Participants who were lost to follow-up or those for whom small cell carcinoma of the cervix was not the primary malignant tumour were excluded from the multi-institutional registry, and those with an unknown surgery status (in addition to those for whom small cell carcinoma of the cervix was not the primary malignant tumour) were excluded from the SEER data. The primary outcome of this study was overall survival (length of time from the date of first diagnosis until the date of death from any cause, or the last follow-up). Kaplan-Meier analysis, propensity score matching, and Cox-regression analyses were used to assess treatment outcomes and risk factors. FINDINGS: 1288 participants were included in the study; 610 in the SEER cohort and 678 in the Chinese cohort. Both univariable and multivariable Cox regression analysis (SEER hazard ratio [HR] 0·65 [95% CI 0·48-0·88], p=0·0058; China HR 0·53 [0·37-0·76], p=0·0005) showed that surgery was associated with a better prognosis. In subgroup analyses, surgery remained a protective factor for patients with locally advanced disease in both cohorts (SEER HR 0·61 [95% CI 0·39-0·94], p=0·024; China HR 0·59 [0·37-0·95]; p=0·029). Furthermore, the protective effect of surgery was observed among patients with locally advanced disease after propensity score matching in the SEER cohort (HR 0·52 [95% CI 0·32-0·84]; p=0·0077). In the China registry, surgery was associated with better outcomes in patients with stage IB3-IIA2 cancer (HR 0·17 [95% CI 0·05-0·50]; p=0·0015). INTERPRETATION: This study provides evidence that surgery improves outcomes of patients with small cell carcinoma of the cervix. Although guidelines recommend non-surgical methods as first-line treatment, patients with locally advanced disease or stage IB3-IIA2 cancer might benefit from surgery. FUNDING: The National Key R&D Program of China and the National Natural Science Foundation of China.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Chu T, Meng Y, Wu P, et al. The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry. Lancet Oncol. 2023. PMID: 37269846. doi:10.1016/S1470-2045(23)00185-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。